2015-2019 POC/Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

September 2015 | 238 pages | ID: 2539EF006ABEN
Venture Planning Group

Abstracts

This new 238-page report from VPGMarketResearch contains 38 tables, and provides a comprehensive analysis of thePOC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis- Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. - Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms- Operating/Recovery Suites- ICUs/CCUs- Cancer Clinics- Ambulatory Care Centers- Surgery Centers- Nursing Homes- Birth CentersSales and Market Share Analysis- Sales and market shares of major hematology and flow cytometry reagent and instrument suppliers. Instrument Placements and Installed Base- The report provides estimates of annual placements and total installed base for major hematology and flow cytometry analyzers. Current and Emerging Products- Analysis of hematology and flow cytometry procedures performed in POC testing locations. - Review of leading hematology and flow cytometry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. Technology Review- Emerging technologies and their applications for POC testing. - Comprehensive listings of companies developing or marketing hematology and flow cytometry testing technologies and products, by assay. Competitive Assessments- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D. Strategic Recommendations- Specific opportunities for new hematology and flow cytometry instruments and reagent systems with potentially significant market appeal during the next five years. - Design criteria for POC testing products. - Alternative business expansion strategies.

Potential market entry barriers and risks. MethodologyThis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files. Contains 238 pages and 38 tables

Contents

INTRODUCTION

Global Market Trends and Emerging Technologies
A. DNA Sequencing
B. DNA and RNA Probe Technology
C. Detection Technologies
D. INSTRUMENTATION: Review of Automated and Semi-Automated Analyzers
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
F. Pharmacogenomics
G. Cancer Molecular Diagnostics Testing
  1. OVERVIEW
  2. MAJOR CANCER TYPES
  3. ONCOGENES
H. Genetic Diseases Molecular Diagnostic Testing
  1. OVERVIEW
  2. NUCLEIC ACID AMPLIFICATION
  3. CHROMOSOME IMAGING
  4. GENOMICS TECHNOLOGIES
  5. PROTEOMICS TECHNOLOGIES
  6. CURRENT PHARMACOGENOMIC TESTING
  7. MAJOR DISEASES

1. FORENSIC MOLECULAR DIAGNOSTICS TESTING

  1. OVERVIEW
  2. MULTILOCUS AND SINGLE LOCUS PROBES
  3. THE FBI
  4. DNA PROFILE DATA BANKS
  5. JUDICIAL IMPLEMENTATION
  6. MAJOR CRIME CATEGORIES
  7. FACTORS CONTRIBUTING TO THE DNA PROBE
Major Expansion
J. Paternity Testing/HLA Typing Molecular Diagnostic Testing
K. Other Molecular Diagnostic Testing Applications
L. Competing/Complementing Technologies

FRANCE

A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Market Segment
  Sales Forecasts by Market Segment
  Major Supplier Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Opportunities for New INSTRUMENTATION
B. Opportunities for New Reagent Kits and Test Systems/Panels
C. Opportunities for New IT, Computers, Software and Automation
D. Opportunities for New Auxiliary Products
Design Criteria For Decentralized Testing Products

ALTERNATIVE MARKET PENETRATION STRATEGIES

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

COMPETITIVE PROFILES

  Abbott
  Affymetrix
  Agilent Technologies
  Applied Gene Technologies
  Arca Biopharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biokit
  BioMerieux
  Bio-Rad
  Biotest
  Cepheid
  CellMark Forensics/LabCorp
  Decode Genetics
  Diadexus
  Eiken
  Elitech Group
  Enzo
  Exact Sciences
  Fujirebio
  Grifols
  Hologic/Gen-Probe
  Illumina
  Kreatech/Leica
  Li-Cor Biosciences
  Monogram Biosciences
  Myriad Genetics
  Ortho-Clinical Diagnostics
  Perkin Elmer/Caliper
  Proteome Sciences
  Qiagen
  Roche
  Scienion
  Sequenom
  Shimadzu
  Siemens
  Sierra Molecular
  Takara Bio
  Tecan Group
  Thermo Fisher

APPENDIXES

List Of Tables

LIST OF TABLES

Oncogenes Potential Applications in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
France, Laboratories Performing DNA Sequencing By Market Segment
France, Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France, Molecular Diagnostic Test Volume Forecast By Major Application
France, Molecular Diagnostics Market Forecast By Major Application
France, Molecular Diagnostics Market By Major Supplier